InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Sim Brandon, Co-CEO. Insider active across 3 companies, notably Apollo Medical Holdings, Inc.. Aggregated, 20 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €26k. History available since 13 May 2021. The latest transaction was filed on 5 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Sim Brandon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
7,163 股@ US$38.47Common StockSEC:0001104659-26-106325:0
1,093 股Common StockSEC:0001104659-26-079333:0
201,056 股0Common StockSEC:0001104659-26-040951:0
21,334 股@ US$23.2420.6% 占其流量Common StockSEC:0001104659-26-009940:0
145,642 股0Common StockSEC:0001104659-25-021881:0
34,386 股0Common StockSEC:0001104659-24-116858:0
2,626 股@ US$57.878.5% 占其流量Common StockSEC:0001104659-24-106293:0
37,957 股@ US$41.9991.5% 占其流量Common StockSEC:0001104659-24-049494:0
86,305 股0Common StockSEC:0001104659-24-043668:0
5,020 股@ US$2.4919.5% 占其流量Common StockSEC:0001486189-24-000004:0
36,765 股@ US$0.3420.4% 占其流量Common StockSEC:0001486189-23-000032:0
36,765 股@ US$0.3420.4% 占其流量Common StockSEC:0001486189-23-000029:0
21,008 股@ US$1.1939.7% 占其流量Common StockSEC:0001486189-23-000021:0
380,053 股0Common StockSEC:0001250853-23-000034:0
258,824 股0Common StockSEC:0001250853-22-000098:0
11,113 股0Common StockSEC:0001104659-22-115009:0
108,560 股0Common StockSEC:0001104659-22-075935:0
42,451 股0Common StockSEC:0001628280-21-021868:0
5,426 股@ US$34.8885.6% 占其流量Common StockSEC:0001628280-21-011490:0
1,000 股@ US$31.4014.4% 占其流量Common StockSEC:0001628280-21-010482:0
标准退出：2021年8月11日 (T+90)
20 条申报中的 20 条
About Sim Brandon
Sim Brandon is Co-CEO. He has 19 filings in total, and across the 19 sampled filings from 2021-05-17 to 2026-06-30, buys amount to EUR 25999 and sells to EUR 0. The main filings concern Astrana Health, Inc., Apollo Medical Holdings, Inc. and Cardio Diagnostics Holdings, Inc., with reported amounts including EUR 1476509.761173691, EUR 418427.3012921547, EUR 154713.4530856661, EUR 137544.9878341452, EUR 25999.20021075554 and EUR 23002.80817493575.
